Stocktoria

Privia Health Group, Inc. PRVA

Nasdaq · stock · Services-Health Services · website · IPO 2021-04-29

Privia Health Group, Inc. financials (annual)

Revenue
$817.1M $966.2M $1.36B $1.66B $1.74B $2.12B 202020212022202320242025
Net income
$31.2M -$188.2M -$8.6M $23.1M $14.4M $22.9M 202020212022202320242025
Free cash flow
$38.5M $54.5M $47.1M $80.7M 202020212022202320242025

Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020
Revenue$2.1B$1.7B$1.7B$1.4B$966.2M$817.1M
Operating income$34.2M$17.0M$20.6M-$19.1M-$217.4M$25.4M
Interest expense$500,000$1.1M$1.9M
Income tax$14.2M$10.8M$8.0M-$6.5M-$27.9M-$7.4M
Net income$22.9M$14.4M$23.1M-$8.6M-$188.2M$31.2M
EPS (diluted)$0.18$0.11$0.19$-0.08$-1.83$0.33
Operating cash flow$163.4M$109.3M$80.8M$47.2M$55.1M$38.9M
Free cash flow$80.7M$47.1M$54.5M$38.5M
Cash & equivalents$479.7M$491.1M$389.5M$348.0M$320.6M$84.6M
Total assets$1.4B$1.1B$999.9M$792.8M$686.4M$329.0M
Total liabilities$578.4M$452.3M$392.5M$273.8M$236.2M$185.3M
Shareholders' equity$790.9M$683.4M$607.4M$519.0M$450.2M$146.7M

Growth · year-over-year · Revenue CAGR 21%

MetricFY2025FY2024FY2023FY2022FY2021FY2020
Revenue growth+22.3%+4.7%+22.2%+40.4%+18.3%
Net income growth+59.3%-37.7%-702.5%
EPS growth+63.6%-42.1%-654.5%
Free cash flow growth+71.3%-13.6%+41.5%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.